Cellebrite DI Quarterly Balance Sheet
NASDAQ: CLBTTechnologyComputer Software: Prepackaged SoftwareUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cellebrite DI financial position
As of Dec 31, 2025, Cellebrite DI reported total assets of $938.9 million, up 176.3% from a year earlier against total liabilities of $454.5 million. Shareholders' equity stood at $484.3 million, or 51.6% of assets. The company held $124.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 1.56, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Cellebrite DI balance sheet (quarterly)
| Quarter (USD) | Q4 20252025-12-31 | Q4 20242024-12-31 | Q4 20222023-12-31 | Q4 20222022-12-31 | Q4 20212021-12-31 | Q4 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 124.46M | 191.66M | 189.52M | 87.64M | 145.97M | 128.71M |
| Short-Term Investments | 151.54M | 101.82M | 38.69M | 44.64M | 0 | — |
| Receivables | 104.97M | 82.36M | 77.27M | 78.76M | 67.50M | 66.32M |
| Inventory | 7.60M | 8.94M | 9.94M | 10.18M | 6.51M | 4.75M |
| Total Current Assets | 575.85M | 567.59M | 422.08M | 295.93M | 273.21M | 324.27M |
| Property, Plant & Equipment | 22.21M | 17.00M | 15.90M | 17.26M | 16.76M | 16.11M |
| Goodwill | 119.56M | 28.71M | 26.83M | 26.83M | 26.83M | 9.46M |
| Intangible Assets | 81.47M | 11.31M | 10.59M | 11.25M | 11.23M | 6.61M |
| Long-Term Investments | 97.96M | 36.60M | 28.86M | 22.13M | 0 | — |
| Total Assets | 938.85M | 690.57M | 532.88M | 403.29M | 339.78M | 364.39M |
| Accounts Payable | 16.83M | 11.08M | 8.28M | 4.61M | 9.55M | 4.73M |
| Total Current Liabilities | 369.66M | 295.50M | 253.82M | 207.78M | 186.57M | 159.38M |
| Total Liabilities | 454.53M | 354.55M | 498.67M | 329.43M | 413.13M | 199.38M |
| Shareholders' Equity | 484.32M | 336.02M | 34.21M | 73.86M | -73.35M | 63.80M |
| Retained Earnings | -86.54M | -164.86M | 118.14M | 199.24M | 78.44M | 28.34M |
| Net Cash (Debt) | 276.00M | 293.48M | 228.21M | 132.29M | 145.97M | 128.71M |
| Shares Outstanding | 248.58M | 234.52M | 203.23M | 193.01M | 187.68M | 124.67M |
This table shows 6 quarterly periods of Cellebrite DI's balance sheet, from Q4 2025 back to Q4 2020, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CLBT's reporting calendar. What is a balance sheet?